700 patients110,866 observations180 daysLIVE

Patient P-02602

Synthetic patientMETA-24 · Day 100 · 55–64 · F · baseline S20Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
4%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S20
  2. Day 14 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 HY-01 recommendedHydration Protocol HY-01
  4. Day 23 Patient acceptedStarted HY-01 in the companion
  5. Day 27 GI symptom burden −30% vs expectedHydration Protocol HY-01
  6. Day 33 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • GI instability-11
  • Nutritional resilience+9
  • Inflammatory activity-7
  • Toxicity-3

What helped?

  • Hydration Protocol HY-01Day 22
    Result: symptom burden −30%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
76 min
improving · +5.9 vs previous 14 d
Sleep duration
Wearable
6.6 h
improving · +0.3 vs previous 14 d
Energy level
Daily log
6.2/10
improving · +0.4 vs previous 14 d
Steps
Wearable
9,334
improving · +701 vs previous 14 d
GI burden
Companion
13.2/100
improving · -12.5 vs previous 14 d
Adherence
Companion
98.1 %
stable · +3.0 vs previous 14 d
Sleep quality
Wearable
47.3/100
improving · +7.7 vs previous 14 d
Glucose, CGM daily mean
CGM
121 mg/dL
improving · -8.2 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 81 from the failing basin, 27 from restoration.

Good elements to keep
  • Hydration Protocol HY-01
    intervention · steering +48.7
  • Protein (supports)
    perturbation · steering +13.5
  • Protein
    supporter · GI -6.4 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Poor metabolizer
    hidden · steering -12.7
  • Ultra-processed food
    perturbation · steering -9.1
  • Simple carbohydrates
    perturbation · steering -7.9
  • Ultra-processed food
    detractor · GI +5.8 next day
  • Caffeine
    detractor · GI +5.3 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -6.4supporter · 95%
  • Ultra-processed food
    +5.8detractor · 95%
  • Caffeine
    +5.3detractor · 95%
  • Simple carbohydrates
    +5detractor · 95%
  • Dietary fat load
    +4.9detractor · 95%
  • Alcohol
    +1.4no signal · 35%
  • Histamine load
    +1.3no signal · 23%
  • Insoluble fibre
    +0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 30/100
    • MicrobiomeF. prausnitzii depleted
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.3 · butyrate capacity 30/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
51 ms
Sleep
6.3 h
Steps
9,556
Resting HR
63 bpm
Daily log: GI score 13, nutritional resilience 73, adherence 98.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0204830%S0277
P-0258432%S0975
P-0239731%S2074
P-0262331%S0374
P-0237431%S0774
P-0238631%S0973
P-0236532%S0872
P-0269833%S06ME-01improved71
P-0240332%S0371
P-0233533%S0470
P-0206230%S2070
P-0221437%S08SC-12no change69